{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T16:51:53Z","timestamp":1769359913705,"version":"3.49.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000005929","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:05:45Z","timestamp":1495573545000},"page":"e5929","source":"Crossref","is-referenced-by-count":16,"title":["Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population"],"prefix":"10.1097","volume":"96","author":[{"given":"Rui-Jian","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MAJ.0b013e31820f8b29","article-title":"Structural bone changes in spondyloarthritis: mechanisms, clinical impact and therapeutic considerations","volume":"341","author":"Schett","year":"2011","journal-title":"Am J Med Sci"},{"key":"R2-28-20210226","doi-asserted-by":"crossref","first-page":"738","DOI":"10.6061\/clinics\/2015(11)04","article-title":"Serum from patients with ankylosing spondylitis can increase ppard, fra-1, mmp7, opg and rankl expression in mg63 cells","volume":"70","author":"Hu","year":"2015","journal-title":"Clinics (Sao Paulo"},{"key":"R3-28-20210226","first-page":"262","article-title":"The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis","volume":"40","author":"Ersozlu-Bozkirli","year":"2015","journal-title":"Acta Reumatol Port"},{"key":"R4-28-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-008-0809-z","article-title":"Prevalence of rheumatic diseases and disability in china","volume":"29","author":"Xiang","year":"2009","journal-title":"Rheumatol Int"},{"key":"R5-28-20210226","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.44.6.359","article-title":"Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, Northern Norway","volume":"44","author":"Gran","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"R6-28-20210226","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00296-016-3441-3","article-title":"Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial","volume":"36","author":"Silte Karamanlioglu","year":"2016","journal-title":"Rheumatol Int"},{"key":"R7-28-20210226","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10067-015-2939-5","article-title":"Performance of ultrasound to monitor achilles enthesitis in patients with ankylosing spondylitis during tnf-a antagonist therapy","volume":"34","author":"Wang","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R8-28-20210226","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11096-015-0124-1","article-title":"Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice","volume":"37","author":"Escudero-Vilaplana","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"R9-28-20210226","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/PPA.S33109","article-title":"Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis","volume":"7","author":"Senabre-Gallego","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"R10-28-20210226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/187152010794474019","article-title":"Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents","volume":"10","author":"Lee","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"R11-28-20210226","first-page":"11","article-title":"Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy","volume":"4","author":"Li","year":"2011","journal-title":"Pharmgenomics Pers Med"},{"key":"R12-28-20210226","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200443090-00001","article-title":"The mdr1 (abcb1) gene polymorphism and its clinical implications","volume":"43","author":"Ieiri","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R13-28-20210226","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eplepsyres.2015.05.015","article-title":"Abcb1\u200ag2677t\/a polymorphism is associated with the risk of drug-resistant epilepsy in asians","volume":"115","author":"Yu","year":"2015","journal-title":"Epilepsy Res"},{"key":"R14-28-20210226","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1528-1167.2008.01858.x","article-title":"Polymorphism of the mdr1\/abcb1 c3435t drug-transporter and resistance to anticonvulsant drugs: a meta-analysis","volume":"50","author":"Bournissen","year":"2009","journal-title":"Epilepsia"},{"key":"R15-28-20210226","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1590\/S0100-879X2008000900005","article-title":"Abcb1 c1236t, g2677t\/a and c3435t polymorphisms in systemic lupus erythematosus patients","volume":"41","author":"Gonzalez","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"R16-28-20210226","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2217\/pgs.13.151","article-title":"Abcb6, abcb1 and abcg1 genetic polymorphisms and antidepressant response of ssris in Chinese depressive patients","volume":"14","author":"Huang","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R17-28-20210226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pharep.2013.09.004","article-title":"Abcb1 c3435t polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population","volume":"66","author":"Ozbey","year":"2014","journal-title":"Pharmacol Rep"},{"key":"R18-28-20210226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/14622416.7.4.551","article-title":"Abcb1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients","volume":"7","author":"Seo","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R19-28-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the new york criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R20-28-20210226","first-page":"1751","article-title":"Baseline factors that influence asas 20 response in patients with ankylosing spondylitis treated with etanercept","volume":"32","author":"Davis","year":"2005","journal-title":"J Rheumatol"},{"key":"R21-28-20210226","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","article-title":"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dougados","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R22-28-20210226","doi-asserted-by":"crossref","first-page":"e89622","DOI":"10.1371\/journal.pone.0089622","article-title":"The functional influences of common abcb1 genetic variants on the inhibition of p-glycoprotein by antrodia cinnamomea extracts","volume":"9","author":"Sheu","year":"2014","journal-title":"PLoS One"},{"key":"R23-28-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.20.391","article-title":"Mdr1 genotype-related pharmacokinetics: fact or fiction?","volume":"20","author":"Sakaeda","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"R24-28-20210226","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1271\/bbb.100816","article-title":"Abc proteins protect the human body and maintain optimal health","volume":"75","author":"Ueda","year":"2011","journal-title":"Biosci Biotechnol Biochem"},{"key":"R25-28-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/14622416.8.8.1075","article-title":"Silent snps: impact on gene function and phenotype","volume":"8","author":"Komar","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R26-28-20210226","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40262-015-0267-1","article-title":"Impact of genetic polymorphisms of abcb1 (mdr1, p-glycoprotein) on drug disposition and potential clinical implications: update of the literature","volume":"54","author":"Wolking","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"R27-28-20210226","first-page":"57","article-title":"Simultaneous analysis of multidrug resistance 1(mdr1) c3435t, g2677t\/a, and c1236t genotypes in hamadan city population, west of iran","volume":"19","author":"Saidijam","year":"2015","journal-title":"Iran Biomed J"},{"key":"R28-28-20210226","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.4238\/2011.December.14.7","article-title":"Analysis of common mdr1 (abcb1) gene c1236t and c3435t polymorphisms in turkish patients with familial mediterranean fever","volume":"10","author":"Rustemoglu","year":"2011","journal-title":"Genet Mol Res"},{"key":"R29-28-20210226","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1734-1140(11)70593-X","article-title":"Frequency of the c1236t, g2677t\/a and c3435t mdr1 gene polymorphisms in the serbian population","volume":"63","author":"Milojkovic","year":"2011","journal-title":"Pharmacol Rep"},{"key":"R30-28-20210226","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000319361","article-title":"Antidepressants and abcb1 gene c3435t functional polymorphism: a naturalistic study","volume":"62","author":"Menu","year":"2010","journal-title":"Neuropsychobiology"},{"key":"R31-28-20210226","first-page":"4955","article-title":"Mdr1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients","volume":"62","author":"Illmer","year":"2002","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:17Z","timestamp":1620960137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702030-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005929","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}